# Flomoxef

## Flumarin inj 1gm

| TAH Drug Code      | [IFMR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFMR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Severe infections caused by the following susceptible pathogens: Staphylococcus spp.， Streptococcus spp. (excluding Enterococcus)， Pneumococcus， Peptostreptococcus spp.， Branhamella catarrhalis， Neisseria gonorrhoeae， Escherichia coli， Klebsiella spp.， Proteus spp.， Haemophilus influenzae， and Bacteroides spp.                                                                                                                                                                                                                                                                                                              |
| Dosing             | Adult: 1-4 g/day IV Q6H-Q12H in divided doses. Children: 60-150 mg/kg/day IV Q6H-Q8H in divided doses. Neonates and preterm infants: 20 mg/kg IV Q8H-Q12H within 3 days of birth， then Q6H-Q8H from the 4th day after birth (maximum dose: 150 mg/kg/day Q6H-Q8H)                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Patients with a history of shock following exposure to any of the ingredients in this product. RELATIVE CONTRAINDICATIONS: Patients with a history of hypersensitivity to any of the ingredients in this product or to other cephalosporin antibiotics Careful Administration: Patients with a history of hypersensitivity to penicillins. Patients with a personal or familial predisposition to allergic reactions such as bronchial asthma， rash and urticaria. Patients with severe renal dysfunction. Patients of poor oral ingestion， patients receiving parenteral feeding， or patients in poor general condition. Elderly patients. |
| Adverse Effects    | Rash， Anemia (decreased RBC， decreased hemoglobin， decreased hematocrit)， eosinophilia， granulocytopenia， Increased SGOT(AST)， increased SGPT (ALT)， increased Al-P， increased gamma-GTP， Diarrhea.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/flomoxef-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

